Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

6. TRASTORNOS CONCURRENTESdepression. American Journal of Psychiatry, 141:525–529.Ferry LH, Burchette RJ (1994) Evaluation of buproprion versus placebo fortreatment of nicotine dependence. In: American Psychiatric Association NewResearch, Washington, DC, EE.UU. American Psychiatric Press:199–200.Finch DM (1996) Neurophysiology of converging synaptic inputs from the ratprefrontal cortex, amygdala, midline thalamus, and hippocampal formation ontosingle neurons of the caudate/putamen and nucleus accumbens. Hippocampus,6:495–512.Freedman R y colab. (1997) Linkage of a neurophysiological deficit in schizophreniato a chromosome 15 locus. Proceedings of the National Academy ofSciences of the United States of America, 94:587–592.Frye MA y colab. (2003) Gender differences in prevalence, risk, and clinical correlatesof alcoholism comorbidity in bipolar disorder. American Journal ofPsychiatry, 160:883-889.Fryer JD, Lukas RJ (1999) Noncompetitive functional inhibition at diverse,human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine,and ibogaine. Journal of Pharmacology and Experimental Therapeutics,288:88–92.Fu Y y colab. (2000) Systemic nicotine stimulates dopamine release in nucleusaccumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in theventral tegmental area. Journal of Pharmacology and Experimental Therapeutics,294:458–465.Funahashi S, Kubota K (1994) Working memory and prefrontal cortex.Neuroscience Research, 21:1–11.Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatricdiagnosis in cocaine abusers: clinical observations. Archives of General Psychiatry,43:107–113.George TP y colab. (1995) Effects of clozapine on smoking in chronic schizophrenicoutpatients. Journal of Clinical Psychiatry, 56:344–346.George TP y colab. (2000) Nicotine transdermal patch and atypical antipsychoticmedications for smoking cessation in schizophrenia. American Journal ofPsychiatry, 157:1835–1842.George TP y colab. (2002) Effects of smoking abstinence on visuospatial workingmemory function in schizophrenia. Neuropsychopharmacology, 26:75–85.Gerding LB y colab. (1999) Alcohol dependence and hospitalization in schizophrenia.Schizophrenia Research, 38:71–75.Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: BloomFE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. NuevaYork, NY, EE.UU. Raven Press:787–798.Geyer MA, Markou A (2002) The role of preclinical models in the developmentof psychotropic drugs. en: Charney D y colab., eds. Psychopharmacology: the fifthgeneration of progress. Hagerstown, MD: Lippincott, Williams yWilkins:445–455.Gheorvassaki EG y colab. (1992) Effects of acute and chronic desipramine treatmenton somatostatin receptors in brain. Psychopharmacology, 108:363–366.195
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASGioanni Y y colab. (1999) Nicotinic receptors in the rat prefrontal cortex:increase in glutamate release and facilitation of mediodorsal thalamo-corticaltransmission. European Journal of Neuroscience, 11:18–30.Glassman AH (1993) Cigarette smoking: implications for psychiatric illness.American Journal of Psychiatry, 150:546–553.Glassman AH y colab. (1988) Heavy smokers, smoking cessation, and clonidine:results of a double-blind, randomized trial. Journal of the American MedicalAssociation, 259:2863–2866.Glassman AH y colab. (1990) Smoking, smoking cessation, and major depression.Journal of the American Medical Association, 264:1546–1549.Glynn SM, Sussman S (1990) Why patients smoke. Hospital and CommunityPsychiatry, 41:1027–1028.Goeders NE, Bienvenu OJ, de Souza EB (1990) Chronic cocaine administrationalters corticotropin-releasing factor receptors in the rat brain. Brain Research,531:322–328.Goff DC, Henderson DC, Amico E (1992) Cigarette smoking in schizophrenia:relationship to psychopathology and medication side effects. American Journal ofPsychiatry, 149:1189–1194.Goldman-Rakic PS (1995) Cellular basis of working memory. Neuron, 14:477–485.Gonzalez P y colab. (1997) Decrease of tolerance to, and physical dependenceon, morphine by glutamate receptor antagonists. European Journal ofPharmacology, 332:257–262.Goodwin DW (1992) Alcohol: clinical aspects. En: Lowinson JH y colab., eds.Substance abuse: a comprehensive textbook, 2a edición. Baltimore, MD, EE.UU.Williams y Wilkins:144–151.Grace AA (1995) The tonic/phasic model of dopamine system regulation: its relevancefor understanding how stimulant abuse can alter basal ganglia function.Drug and Alcohol Dependence, 37:111–129.Gray R y colab. (1996) Hippocampal synaptic transmission enhanced by lowconcentrations of nicotine. Nature, 383:713–716.Green AI y colab. (1999) Clozapine for comorbid substance use disorder andschizophrenia: do patients with schizophrenia have a reward-deficiency syndromethat can be ameliorated by clozapine? Harvard Review of Psychiatry,6:287–296.Green AR (1987) Evolving concepts on the interactions between antidepressanttreatments and monoamine neurotransmitters. Neuropharmacology, 26:815–822.Griffith JD y colab. (1972) Dextroamphetamine: evaluation of psychotomimeticproperties in man. Archives of General Psychiatry, 26:97–100.Grillner P, Svensson TH (2000) Nicotine-induced excitation of mid-braindopamine neurons in vitro involves ionotropic glutamate receptor activation.Synapse, 38:1–9.Haertzen CA, Hooks NT Jr (1969) Changes in personality and subjective experienceassociated with the chronic administration and withdrawal of opiates.Journal of Nervous and Mental Disorders, 148:606–614.196
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91:
4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Capítulo 5Bases Genéticas de lasF
Page 148 and 149:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
Page 228: 6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?